Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

Parkinson's is a brain condition which is responsible for uncontrolled movements. It causes difficulty in talking, walking, ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...